Chemoinformaics analysis of 1-Propene, 3,3,3-trifluoro-2-methyl-
Molecular Weight | 110.078 | nRot | 0 |
Heavy Atom Molecular Weight | 105.038 | nRig | 17 |
Exact Molecular Weight | 110.034 | nRing | 0 |
Solubility: LogS | -3.216 | nHRing | 0 |
Solubility: LogP | 1.423 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 12 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 7 | No. of Aromatic Carbocycles | 0 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 5 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 4 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
nHA | 0 | APOL | 11.685 |
nHD | 0 | BPOL | 8.35503 |
QED | 0.701 |
Synth | 3.447 |
Natural Product Likeliness | 2.214 |
NR-PPAR-gamma | 0.17 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.001 |
Pgp-sub | 0.264 |
HIA | 0.018 |
CACO-2 | -4.935 |
MDCK | 0.0000179 |
BBB | 0.396 |
PPB | 0.821638 |
VDSS | 1.086 |
FU | 0.180361 |
CYP1A2-inh | 0.208 |
CYP1A2-sub | 0.604 |
CYP2c19-inh | 0.067 |
CYP2c19-sub | 0.514 |
CYP2c9-inh | 0.062 |
CYP2c9-sub | 0.776 |
CYP2d6-inh | 0.059 |
CYP2d6-sub | 0.427 |
CYP3a4-inh | 0.009 |
CYP3a4-sub | 0.287 |
CL | 8.876 |
T12 | 0.433 |
hERG | 0.014 |
Ames | 0.118 |
ROA | 0.306 |
SkinSen | 0.066 |
Carcinogencity | 0.919 |
EI | 0.011 |
Respiratory | 0.075 |
NR-Aromatase | 0.647 |
Antiviral | No |
Prediction | 0.975309 |